Garrison Point Advisors LLC Sells 92 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Garrison Point Advisors LLC cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,418 shares of the financial services provider’s stock after selling 92 shares during the quarter. Garrison Point Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,377,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. HHM Wealth Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the last quarter. VSM Wealth Advisory LLC bought a new position in iShares Biotechnology ETF during the fourth quarter valued at $30,000. Bradley & Co. Private Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter worth about $32,000. Newbridge Financial Services Group Inc. bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $33,000. Finally, Hager Investment Management Services LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at $34,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 5.4 %

Shares of iShares Biotechnology ETF stock opened at $117.16 on Friday. The company’s 50-day moving average price is $134.95 and its 200-day moving average price is $138.11. The company has a market cap of $5.27 billion, a price-to-earnings ratio of 24.21 and a beta of 0.82. iShares Biotechnology ETF has a 12-month low of $117.02 and a 12-month high of $150.57.

iShares Biotechnology ETF Increases Dividend

The company also recently announced a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were paid a $0.1212 dividend. The ex-dividend date of this dividend was Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.